Button, B., King, S., Wilson, L., Poulsen, M., Williams, E., Rang, C., & Kotsimbos, T. (2023). 447 Respiratory status, physical activity, and other measures of wellness before and after introduction of elexacaftor-tezacaftor-ivacaftor in adults with cystic fibrosis using the Alfred Wellness Score. Journal of Cystic Fibrosis, 22, S235. https://doi.org/10.1016/S1569-1993(23)01372-3
Chicago Style (17th ed.) CitationButton, B., S. King, L. Wilson, M. Poulsen, E. Williams, C. Rang, and T. Kotsimbos. "447 Respiratory Status, Physical Activity, and Other Measures of Wellness Before and After Introduction of Elexacaftor-tezacaftor-ivacaftor in Adults with Cystic Fibrosis Using the Alfred Wellness Score." Journal of Cystic Fibrosis 22 (2023): S235. https://doi.org/10.1016/S1569-1993(23)01372-3.
MLA (9th ed.) CitationButton, B., et al. "447 Respiratory Status, Physical Activity, and Other Measures of Wellness Before and After Introduction of Elexacaftor-tezacaftor-ivacaftor in Adults with Cystic Fibrosis Using the Alfred Wellness Score." Journal of Cystic Fibrosis, vol. 22, 2023, p. S235, https://doi.org/10.1016/S1569-1993(23)01372-3.